India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
Will this drug prove to be a panacea in the treatment of migraine? About one billion people worldwide suffer from severe headaches or migraines. This is such a disease, due to which the headache is unbearable and it is impossible to do daily work. Thus, there is good news for those who are suffering from migraines, there is an effective medicine for curing migraines. According to the news published in BBC, such a medicine has been made to get rid of migraine, which is proving to be very effective. The name of this medicine is Remazipent. According to researchers, this migraine medicine blocks the effect of a chemical called CGRP. This is the same chemical that causes severe headaches. This drug dissolves quickly in the body and stops the effects of the headache before it occurs. After long research, this drug has been approved for general use. The drug has been approved for international use and is being used in 80 countries, including the United States. Also read this Is the head...